Adnexus
Adnexus is a Texas-based biotechnology company pioneering tomorrow's healthcare solutions by bridging biology and technology. Their core focus is the development and commercialization of proprietary proteins and monoclonal antibodies for the treatment of infectious diseases. Adnexus utilizes its Sutra™ AI Platform for early drug discovery and development, identifying conserved and immutable targets on viruses, bacteria, and fungi. This AI-driven approach facilitates the production of broadly neutralizing monoclonal antibodies with a lower risk of immunogenicity. They are actively involved in therapeutic pipelines for various diseases and emphasize a 'One Health' approach, recognizing the interconnectedness of human, animal, and environmental health. The company operates from a lab at the University of Missouri and collaborates with global partners to expedite therapeutic solutions.
Adnexus
Adnexus is a Texas-based biotechnology company pioneering tomorrow's healthcare solutions by bridging biology and technology. Their core focus is the development and commercialization of proprietary proteins and monoclonal antibodies for the treatment of infectious diseases. Adnexus utilizes its Sutra™ AI Platform for early drug discovery and development, identifying conserved and immutable targets on viruses, bacteria, and fungi. This AI-driven approach facilitates the production of broadly neutralizing monoclonal antibodies with a lower risk of immunogenicity. They are actively involved in therapeutic pipelines for various diseases and emphasize a 'One Health' approach, recognizing the interconnectedness of human, animal, and environmental health. The company operates from a lab at the University of Missouri and collaborates with global partners to expedite therapeutic solutions.